Kurma Partners — 2017 Investments
4 investments dated 2017 · listed companies and verified rows first · show all
Cardiologs develops software that uses clinically validated AI and cloud technology to analyze ECGs and support cardiology diagnostics.
AI & Machine LearningDigital HealthMedical Devices
Co-investorsAgoranovIsaiISAI GestionParis-Saclay Seed FundPartech VenturesStartX
Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.
BiotechDeep TechHealthtechMedical DevicesParis, FR
Co-investorsFund+Seroba Life SciencesV-Bio VenturesBpifranceGO CapitalInvus+2 more
Sensome develops medical technology solutions at the intersection of engineering and life sciences, focusing on healthcare applications.
Deep TechHealthtechMedical Devices
Co-investorsParis-Saclay Seed FundPartech VenturesBNP Paribas DéveloppementIdinvest Partners
SmartCatch develops compact microfiltration devices that isolate Circulating Tumor Cells (CTCs) directly from whole blood without pre-analytical steps, enabling liquid biopsy for cancer diagnosis and monitoring.
BiotechDeep TechHealthtechMedical DevicesPortola Valley, US
MARK DAHM(Executive Officer, Director)
BoardRICHARD DEATLEY(Director)ROBERT TERRY(Director)TJ DURNAN(Director)
Co-investorsM Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








